News

According to the company, the patents cover the use of prolactin alone, as well as in combination with other therapeutics that augment recovery and therefore provide a broad

Archemix’s ARC1779 is currently in Phase II clinical development with a clinical trial designed to assess the safety, pharmacokinetics and pharmacodynamic effects of ARC1779 in approximately 28 patients

Under terms of the definitive agreement, Healthscreen agreed to pay a total of $1.3 million for Regent. Of the purchase price, $1 million has been paid to Regent’s

This multinational Phase II study will evaluate the efficacy of IMC-A12 in adult and adolescent patients with several types of previously treated, advanced or metastatic soft tissue sarcoma,

The first patient has received treatment at Guy’s and St Thomas’s NHS Foundation Trust in London. A total of six patients will be entered into this trial at

SpectraCell’s Lp-PLA2 test measures the amount of a specific enzyme in blood that occurs when there is an active atherosclerotic process that could lead to the rupture of

According to the company, the latest generation of the PressureWire Certus features a new ergonomically designed proximal connector which provides three key advantages for physicians. The new large

HERmark is said to be a proprietary diagnostic that accurately quantifies HER2 total protein levels and HER2 homodimerization in patients with breast cancer. According to the company, HERmark

According to the Financial Times, The National Institute of Health and Clinical Excellence (NICE) has issued a provisional recommendation that Tyverb for advanced breast cancer failed to meet